DF
RMD icon

DecisionPoint Financial’s ResMed RMD Stock Holding History

DecisionPoint Financial’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$403 Sell
2
-1
-33% -$207 ﹤0.01% 718
2026
Q1 		$674 Hold
3
– – ﹤0.01% 423
2025
Q4 		$723 Hold
3
– – ﹤0.01% 461
2025
Q3 		$813 Hold
3
– – ﹤0.01% 373
2025
Q2 		$769 Buy
+3
New +$716 ﹤0.01% 360

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

DecisionPoint Financial's RMD Position: Q2 2026 in Review

DecisionPoint Financial reduced its ResMed (RMD) stake by 33% in Q2 2026, selling an estimated $207 and leaving 2 shares worth $403. The position accounts for ﹤0.01% of the portfolio, ranked #718.

DecisionPoint Financial first reported a position in RMD in Q2 2025 and has held it in 5 quarters since. The position peaked at $813 in Q3 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • DecisionPoint Financial held 2 shares of ResMed worth $403 as of Q2 2026.
  • DecisionPoint Financial sold 1 ResMed share in Q2 2026, an estimated $207.
  • ResMed made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #718 holding.
  • DecisionPoint Financial first reported a position in ResMed in Q2 2025 and has held it in 5 quarters since.
  • DecisionPoint Financial's ResMed position peaked at $813 in Q3 2025.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.